
You are here

Topics:
Expertise
Health economics, Applied econometrics, Epidemiological and economic simulation modeling, Impact evaluation, AIDS.
Bio
Mead Over is a senior fellow emeritus at the Center for Global Development researching economics of efficient, effective, and cost-effective health interventions in developing countries. Much of his work since 1987, first at the World Bank and now at the CGD, is on the economics of the AIDS epidemic. After work on the economic impact of the AIDS epidemic and on cost-effective interventions, he co-authored the Bank’s first comprehensive treatment of the economics of AIDS in the book, Confronting AIDS: Public Priorities for a Global Epidemic (1997,1999). His most recent book is Achieving an AIDS Transition: Preventing Infections to Sustain Treatment (2011)in which he offers options, for donors, recipients, activists and other participants in the fight against HIV, to reverse the trend in the epidemic through better prevention. His previous publications include The Economics of Effective AIDS Treatment: Evaluating Policy Options for Thailand (2006). Other papers examine the economics of preventing and of treating malaria. In addition to ongoing work on the determinants of adherence to AIDS treatment in poor countries, he is working on optimal pricing of health care services at the periphery, on the measurement and explanation of the efficiency of health service delivery in poor countries and on optimal interventions to control a global influenza pandemic.
In addition to his numerous research projects at the Center, Over currently serves as a member of PEPFAR’s Scientific Advisory Board and as a member of the Steering Committee of the HIV/AIDS modeling consortium funded by the Bill & Melinda Gates Foundation.
After leaving college, Over served in the US Peace Corps’ first program in Burkina Faso, where he worked with villagers in the construction of 25 water wells. While earning his Ph.D. in economics from the University of Wisconsin at Madison, he spent one year as a Foreign Scholar in the Economics Department of the French National Institute for Agricultural Research (INRA). After leaving Madison, he taught health economics, development economics, applied microeconomics and econometrics as an Assistant Professor of Economics in the Department of Economics and the Center for Development at Williams College in Williamstown, Massachusetts from 1975 through 1981 and as an Associate Professor of Economics at Boston University from 1981 through 1985, where he also held the position of Associate Professor of Public Health.
Recruited to the World Bank as a Health Economist in 1986, Mead Over advanced to the position of Lead Health Economist in the Development Research Group, before leaving the World Bank to join the Center for Global Development in 2006. Each spring since 2005, he has taught a module on “Modeling the Cost-Effectiveness of Interventions against Infectious Diseases” as part of the master’s degree program in health economics for developing countries at the Centre d'Etudes et de Recherches sur le Développement International (CERDI) at the University of the Auvergne, Clermont-Ferrand, France.
- HIV prevention costs and program scale: data from the PANCEA project in five low and middle-income countries BMC Health Services Research, 2007, 7 (1), 108.
- Over, Mead et al., "The economics of effective AIDS treatment in Thailand," AIDS 21 Suppl 4 (July): S105-S116 (2007). Based on the previously pulished book: The Economics of Effective AIDS Treatment Evaluating Policy Options for Thailand World Bank, Washington, DC (2006).
- Antiretroviral therapy and HIV prevention in India: modeling costs and consequences of policy options, Over, M. et al., Sex Transm.Dis. 33 (10 Suppl): S145-S152 (2006).
- Sexually Transmitted Infections by Sevgi Aral and Mead Over, with Lisa Manhart and King Holmes. (2006) Chapter 17 in D. Jamison et al (eds.) Disease Control Priorities.
- Will a global subsidy of artemisinin-based combination treatment (ACT) for malaria delay the emergence of resistance and save lives? Health Affairs, 25, no. 2 (2006): 325-336. (version with demand curves)
- Impregnated Nets or DDT Residual Spraying? Field Effectiveness of Malaria Prevention Techniques in the Solomon Islands, 1993-99, with Patricia Graves, Bernard Bakote’e, Raman Velayudhan, Peter Waleaulo, American Journal of Tropical Medicine and Hygiene, August, 2004, Vol. 71, No. 2 Supplement.
- HIV/AIDS Treatment and Prevention in India Modeling the Costs and Consequences (2004) with Peter Heywood, Julian Gold, Indrani Gupta, Subhash Hira, Elliot Marseille. Human Development Network Health, Nutrition, and Population Series. The International Bank for Reconstruction and Development / The World Bank, Washington, D.C.
- Impact of the HIV/AIDS epidemic on the health sectors of developing countries. (2004). In The macroeconomics of HIV/AIDS. Edited by Markus Haacker. Washington, D.C.: International Monetary Fund.
- "Evaluating the Impact of Organizational Reforms in Hospitals," with Naoko Watanabe, Chapter 3 in A. Preker and A.Harding (eds.) Innovations in health service delivery: The corporatization of public hospitals. World Bank, March 2003
- Sources of Financial Assistance for Households Suffering and Adult Death in Kagera, Tanzania with M.Lundberg and P.Mujinjia. The South African Journal of Economics, 2000, 68 (5) and Working Paper No. 2508, Development Research Group, Infrastructure and Environment, The World Bank, Washington, D.C.
- The Public Interest in a Private Disease: The Government’s role in STD Control, chapter 1 of K.K. Holmes, et al (eds.), Sexually Transmitted Diseases, 3d ed., New York: McGraw-Hill.
- Confronting AIDS: Public Priorities in a Global Epidemic. with Martha Ainsworth, World Bank, 1997, 1999. Summary in English, French, Spanish.
- Confronting AIDS: Evidence from the developing World, (1998) with Martha Ainsworth and Lieve Fransen (eds.) European Union.
- “The effects of societal variables on urban rates of HIV infection in developing countries: An exploratory analysis”, Part I Chapter 2 in Confronting AIDS: Evidence from the developing World, (1998) with Martha Ainsworth and Lieve Fransen (eds.) European Union.
- HIV Infection and Sexually Transmitted Diseases with Peter Piot. (1993) In D.T Jamison and others, eds. Disease Control Priorities in Developing Countries. New York: Oxford University Press, pp-455-527.
More From Mead Over

Recognizing the donors’ obligation to sustain financing for the millions of AIDS patient who would not be alive today without it, this essay proposes a dynamic paradigm for the struggle with the AIDS epidemic—“the AIDS transition” —and argues that to most rapidly achieve an AIDS transition new funding of AIDS treatment should be tightly linked to dramatically improved and transparently measured prevention of HIV infections.
On Sunday the New York Times published four article on the battle against AIDS in Uganda which everyone should read w
This paper proposes a cash-on-delivery approach to reward AIDS programs in accordance with the number of verifiable HIV infections they avert.
Last week was a busy time in Washington for those interested in results-focused approaches to foreign aid, with two m
Pages
Next week some 20,000 AIDS activists, practitioners and researchers from around the world will pour into Washington,
The Wonkcast is taking a brief summer vacation. We've selected this show from our archives- it was originally posted on May 25, 2010.
Even as the cost of treating HIV/AIDS has fallen dramatically, the number of people newly infected has remained high. What can be done to reverse this trend and finally defeat this disease? This week on the Wonkcast, I’m joined by Mead Over, a senior fellow here at the Center for Global Development and perhaps the world’s leading expert on the economics of HIV/AIDS. He has recently published two major essays, which introduce the concept of the “AIDS transition”—the point in time where the number of people living with the disease begins to fall. He argues persuasively that to reach this point, international donors must greatly strengthen incentives for effective prevention.
On Sunday the New York Times published four article on the battle against AIDS in Uganda which everyone should read w
In this series of briefs, Center for Global Development experts present concrete, practical policy proposals that will promote growth and reduce poverty abroad. Each can make a difference at virtually no incremental cost to US taxpayers. Together, they can help secure America’s preeminence as a development and security power and partner.
This is a joint post with Josh Busby
Our research on the political economy of antiretrovirals (ARVs) is motivated by a key puzzle: why were AIDS activists and AIDS policy entrepreneurs successful in putting universal access to treatment on the international agenda when so many other global campaigns--whether in health care or other issue areas like climate change--have either failed or struggled to have much impact. In our paper, we make the case that the market for ARVs was politically constructed, meaning that activists had to bring the demand and supply sides of the market together through a variety of tactics and strategies (Tim Bartley makes a similar argument on forest certification schemes).
Pages
There is no content currently that matches this filter.
Commentary Menu